Professor, Department of Pharmaceutics; Affiliate Member of Clinical Pharmacology, Fred Hutchinson Cancer Research Center; Affiliate Faculty, UW Center for AIDS Research
PhD, University of Tennessee; Bachelor of Science, University of California
- Elucidating mechanisms of protein and drug disposition, and genetic basis of inter-individual variation in therapeutic responses
- Drug delivery strategies for treatment of AIDS and cancers using drugs, DNA, proteins and antigens
Dr. Ho is a professor of pharmaceutics and UW presidential entrepreneurial fellow. He holds appointments at the Institute of Translational Health Sciences, Center on Human Development & Disability and Fred Hutchinson Cancer Research Center. His research involves drug targeting and translational medicine. He is noted for linking drug levels at target sites in the body to disease symptoms.
Building on the knowledge of target cells and tissues pivotal to disease progressions, he develops nanomedicine and device-enabled technologies that make anti-infective agents such as HIV, pain and cancer medications more effective and safe. He completed an Infectious Diseases Fellowship at Stanford University. Dr. Ho has been elected to fellow status at the American Association for the Advancement of Science and the American Association of Pharmaceutical Scientists. He has received some of his field's highest honors, including the American Association of Colleges of Pharmacy’s Dawson Biotechnology Award and the AAPS Biotechnology Lifetime Achievement Award. He has received continuous major research funding from the National Institutes of Health (NIH) that has led to over 100 publications related to improving drug delivery, transport, metabolism, safety and effectiveness.
Dr. Ho promotes public understanding of biotechnology and health, and authored, "Biotechnology and Biopharmaceuticals: Transforming Proteins and Gene into Drugs." He serves as scientific and board advisor to private and public organizations, including the NIH.